Monoclonal Antibodies Capable of Inhibiting Complement Downstream of C5 in Multiple Species

Overview of attention for article published in Frontiers in immunology, December 2020

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 19 Dimensions

Readers on

mendeley: 34 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 19 publications that cite this research output.

19

The most recent citing publications are shown below. View all 19 publications that cite this research output on Dimensions.

Humanization of a mouse anti-human complement C6 monoclonal antibody as a potential therapeutic for certain complement-mediated diseases

Article in Molecular Immunology (April 2024)

Targeting terminal pathway reduces brain complement activation, amyloid load and synapse loss, and improves cognition in a mouse model of dementia

Article in Brain Behavior and Immunity (March 2024)

Review of Satralizumab for Neuromyelitis Optica Spectrum Disorder: A New Biologic Agent Targeting the Interleukin-6 Receptor

Article in Cureus (February 2024)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.